SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Shares of SLS are declining as traders react to a surge in market volatility and social media-driven uncertainty regarding the timing and potential outcome of the REGAL trial. The conversation is largely characterized by a clash between investors holding for a long-term catalyst and those reacting to speculative reports that have fueled concerns over trial success and potential management issues.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo shares are trending following the launch of a new $1 billion at-the-market equity offering program, which has intensified concerns regarding shareholder dilution. While some traders view the decline as an opportunity to initiate or add to positions given the company's long-term pipeline and balance sheet, others express frustration with the ongoing capital raises and consistent insider selling.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are experiencing significant volatility following a strong fiscal first-quarter earnings report, with the community divided between those citing a disconnect from fundamentals and others pointing to options market manipulation and debt concerns. While sentiment remains broadly bullish on the company's AI-driven growth and cloud backlog, the stock has struggled to hold early gains amid intense debate over the impact of heavy capital expenditure and potential insider selling.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and social media attention as traders debate the potential impact of ongoing infrastructure developments, such as the Onyx Mesh and planned neobank integration. While bulls point to these technical milestones and accumulation signals, others express skepticism, frequently citing concerns over price dilution, historical sell-offs, and perceived lack of transparency.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

SMR is trending downward following a UBS downgrade to 'Sell,' with analysts highlighting concerns over long construction timelines, limited customer commitments, and ongoing cash burn. While retail sentiment remains mixed, many traders are debating whether the recent price decline represents an overreaction or a necessary adjustment given the company's lack of commercial revenue.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech shares are experiencing significant selling pressure following the announcement that its co-founders will step down by the end of the year to establish a separate company, coupled with a reported quarterly loss and a weakened revenue outlook for 2026. While some investors view the drop as an overreaction and a potential buying opportunity given the company's substantial cash reserves and extensive oncology pipeline, many are concerned by the leadership transition and the absence of clear succession plans.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

The conversation is largely centered on the company's recent photonic chip packaging milestone, with traders debating whether this technical advancement justifies the valuation or if the stock faces significant downside risk due to ongoing cash burn, dilution concerns, and speculation surrounding a potential government contract. Many participants are also closely watching the 180-day lockup expiration for early shareholders, which has become a primary point of uncertainty and contention among investors.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors debate the impact of mixed Phase 3 psoriatic arthritis data alongside ongoing concerns regarding management's communication and the potential for long-term dilution. While some traders view the recent price decline as an attractive buying opportunity due to the company's strong cash position and the upcoming FDA filing for its lead drug, others remain skeptical, citing a crowded market and lack of a near-term buyout catalyst.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is heavily criticizing the token as a "rug pull" after it experienced a significant and rapid price collapse shortly following its launch. Traders are expressing widespread frustration and mockery regarding the project's legitimacy, with many labeling it a scam.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending following positive Phase 3 clinical trial results for its COPD drug, tozorakimab, which showed a statistically significant reduction in flare-ups compared to a placebo. This success has revitalized investor sentiment toward the IL-33 pathway and supports the company's long-term blockbuster sales forecast for the treatment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


rikvip8uknet

RIKVIP